Reducing Suicide Risk Through Targeted Pharmacological Strategies

Speaker: Thanompong Sathienluckana
Siam University, Thailand
Session Type: Oral Presentation 
Talk Title: Pharmacological pathways for suicide reduction inpsychiatric patients

🧠 Session Overview
∙ A Critical Global Issue: Suicide remains a leading cause of death globally, with over 700,000 deaths each year and a strong association with psychiatric disorders.
∙ Understanding the Biology: This talk explores key neurobiological mechanisms involved in suicidality, including serotonin dysregulation, neuroinflammation, reduced BDNF, and HPA-axis hyperactivity.
∙ Current Treatment Gaps: Despite advances in psychiatry, no medication is specifically approved for acute suicidal crises—highlighting the need for optimized pharmacotherapy.
∙ Risk-Focused Management: Emphasis on addressing contributory factors such as sleep problems, substance use, medication non-adherence, comorbid illnesses, and psychosocial stressors.
∙ Evidence-Based Medications:
– Clozapine: Proven to lower suicide risk in schizophrenia and schizoaffective disorder, with effects beyond antipsychotic action.
– Lithium: Demonstrates robust anti-suicidal benefits in mood disorders, independent of mood stabilization.
– Ketamine & Intranasal Esketamine: Rapid-onset reduction of depressive symptoms and suicidal ideation in treatment-resistant depression.
– SSRIs: Effective in reducing suicide risk in adults and older populations, with age-specific considerations in younger patients.
∙ Clinical Insight: Highlights the importance of correct dosing, continuity of treatment, and close monitoring to prevent relapse and suicidality.

👨‍⚕️ Meet the Speaker
Thanompong Sathienluckana, PharmD, BCP, serves as Associate Dean for Academic Services at the Faculty of Pharmacy, Siam University, and Academic Chair of the Pharmacotherapy Council of Thailand.
∙ Clinical pharmacist at Somdet Chaopraya Institute of Psychiatry, Bangkok
∙ Specialist in neurologic and psychiatric pharmaceutical care
∙ PharmD graduate from Srinakharinwirot University
∙ Board Certified in Pharmacotherapy

🔗 Attend the Conference
International Conference on Addiction Medicine, Mental Health and Psychiatry
📅 March 23–25, 2026
📍 Singapore & Online
📝 Register Now: https://addiction.miconferences.com/register

#MentalHealth2026 #AddictionMedicineConference #PsychiatryResearch #SuicidePrevention #Psychopharmacology #ClinicalPharmacy #GlobalMentalHealth #EvidenceBasedCare #SingaporeEvents #HealthcareInnovation #MICONFERENCES #MentalHealthProfessionals #RecoveryPathways #SingaporeConference #HybridConference #MIC2026

Healing at the Root: Emotional Regression as a Transformative Clinical Tool

🎙️ Keynote Speaker Feature: Aaron Olson
Program Director, Cirque Lodge, United States
📌 Session Format: Oral Presentation (Onsite & Virtual)
📘 Session Title: WalkingBackwards: Using Emotional Regression as a Therapeutic Entry Point in SubstanceUse Disorders, Anger, and Grief

---

🧠 Session Overview & Key Insights

▪ Central Theme: Re-envisioning emotional regression as a clinical opportunity that opens pathways to deep healing.
▪ Clinical Relevance: Highlights how substance dependence, persistent anger, and unresolved grief often stem from early relational trauma and emotional injury.
▪ Conceptual Integration: Draws from psychoanalytic foundations, family systems theory, and Acceptance & Commitment Therapy (ACT).
▪ Therapeutic Strategy: Demonstrates how accessing regressive emotional states helps clinicians move past cognitive defenses to reach core developmental wounds.
▪ Applied Techniques: Family identity mapping, genograms, guided imagery, somatic awareness, and narrative repair.
▪ Trauma-Sensitive Practice: Emphasizes safety, containment, and non-retraumatizing interventions.
▪ Clinical Impact: Supports improved emotional regulation, increased psychological flexibility, and strengthened self-compassion.
▪ Practice in Action: Case vignettes illustrating effective regression-focused interventions in SUD, anger, and grief treatment.
▪ Key Message: Regression work is a gateway to sustainable recovery—not an endpoint.

---

👨‍⚕️ Speaker Profile

With more than three decades of experience in behavioral health, Aaron Olson has been a cornerstone of Cirque Lodge since 2009. His career spans juvenile justice, inpatient psychiatry, residential and outpatient addiction treatment, and community mental health settings.

▪ Expertise in substance use disorders and family systems therapy
▪ Strong ACT-based clinical framework
▪ Special interests include intergenerational trauma, clinician burnout, compassion fatigue, and emotional regression
▪ National speaker on advanced therapeutic approaches
▪ Program Director of Cirque Lodge’s Lodge Program
▪ Faculty member, University of Utah – College of Social Work, Substance Abuse Counseling Program

---

🌐 Be Part of the Global Conversation

📍 InternationalConference on Addiction Medicine, Mental Health and Psychiatry
📅 March 23–25, 2026
📌 Singapore & Online
🔗 Conference Website: https://addiction.miconferences.com/

#AddictionMedicine #MentalHealth2026 #PsychiatryConference #TraumaHealing #SubstanceUseTreatment #ACTTherapy #BehavioralHealthExperts #FamilySystems
#GriefCounseling #AngerManagement #MentalWellbeing #ClinicalInnovation
#HybridConference #SingaporeEvents #MIC2026

Integrated Care for Youth with Disruptive Behavior Disorders & Cannabis Use Disorder

Presenter: Tammy Seeker, D.S.W., LCSW, LCDC
(Angelo State University, United States)
Presentation Type: Oral Presentation
Title: The Assessment and Treatment ofDisruptive Behavior Disorders Comorbid with Cannabis Use Disorder

---

🔍 Presentation Highlights
∙ Focus: Understanding the complex co-occurrence of disruptive behavior disorders (DBDs) and cannabis use disorder (CUD) among youth.
∙ Clinical Challenge: Youth with DBDs + CUD face elevated risks of family conflict, academic failure, and juvenile justice involvement.
∙ Assessment Tools: Use of structured interviews, behavior checklists, and validated substance use screeners for accurate diagnosis.
∙ Risk Framework: Examination of biopsychosocial risk factors influencing comorbidity and treatment outcomes.
∙ Evidence-Based Treatments:
 – CBT: Enhances emotion regulation and problem-solving skills.
 – MST: Reduces delinquency and substance use through family and peer system interventions.
 – MI: Builds motivation and readiness for change.
 – Contingency Management: Demonstrates effectiveness in reducing cannabis use.
∙ Key Insight: Integrated, multisystemic, and family-involved approaches yield the strongest outcomes.
∙ Future Impact: Early, coordinated intervention leads to reduced recidivism and improved long-term functioning.

---

👩‍⚕️ About the Speaker
Tammy D. Seeker, D.S.W., LCSW, LCDC, is an Adjunct Instructor and Program Coordinator at Angelo State University.
∙ Doctorate in Social Work from Angelo State University.
∙ Extensive clinical and administrative experience in behavioral health, substance use treatment, and criminal justice.
∙ Research interests include justice-involved youth, integrated substance use treatment in hospital settings, and workforce development in social services.

---

🔗 Join the Conference
Event: International Conference on Addiction Medicine, Mental Health andPsychiatry
📅 March 23–25, 2026
📍 Singapore & Online
🌐 Website: https://addiction.miconferences.com/

#AddictionMedicine #MentalHealthConference #PsychiatryConference #SubstanceUseDisorder #CannabisUseDisorder #BehavioralHealth #YouthMentalHealth #EvidenceBasedPractice #CBT #MultisystemicTherapy #MotivationalInterviewing #JusticeInvolvedYouth #MentalHealthProfessionals #SingaporeConference #HybridConference #MIConferences

Overdose Data to Action: Using Health Informatics to Drive Addiction Prevention

Presenter: Prof. Sue Feldman, RN, MEd, PhD, FACMI 
(University of Alabama at Birmingham, United States)
Presentation Type: Oral Presentation (In-Person / Online)
Title: Overdose data to action: Toward addiction prevention usingdata in Alabama

---

🔍 Presentation Highlights
∙ Focus: Leveraging overdose surveillance and health informatics to inform addiction prevention strategies.
∙ Challenge: Despite reduced opioid prescriptions, overdose deaths in Alabama continue to rise.
∙ Approach: Sequential monthly data collection from 11 stakeholder groups, emphasizing peer navigation as a key linkage to care.
∙ Data Strategy: Aggregation by ZIP code to identify high-need areas and guide targeted interventions.
∙ Community Impact:
– 38 community & faith-based events reaching ~12,000 individuals
– 1,589 linkages to care through peer navigation
– 75% of attendees at events received direct services
∙ Surveillance Success: Hospital participation increased to 93 out of 94, supported by enhanced data visualization.
∙ Prevention & Harm Reduction:
– 3,000+ naloxone kits distributed across 94 ZIP codes
– 21,000+ harm reduction service encounters
– 600+ trainings on fentanyl test strip usage
∙ Policy & Practice: Improved PDMP participation with 400+ additional prescribers and hospital-based clinical alerts.
∙ Outcome: Demonstrates the power of data-driven, community-centered, and iterative approaches to addiction prevention.

---

👩‍⚕️ About the Speaker
Prof. Sue Feldman is a Professor and Director of Graduate Programs in Health Informatics at the University of Alabama at Birmingham.
∙ Internationally recognized expert in health information systems for social good
∙ Research funded by the World Bank, Asian Development Bank, CDC, and CMS
∙ Recipient of Changemaker in Health, Mentor of the Year, and Faculty Innovator of the Year awards
∙ Graduate of Claremont Graduate University

---

🔗 Join the Conference
Event: International Conference on Addiction Medicine, Mental Health andPsychiatry
📅 March 23–25, 2026 | 📍 Singapore & Online
🌐 Website: https://addiction.miconferences.com/

---

#AddictionMedicine #MentalHealthConference #Psychiatry2026 #OverdosePrevention #PublicHealth #HealthInformatics #OpioidCrisis #HarmReduction #Naloxone #DataDrivenHealth #GlobalHealth #SingaporeConference #AddictionResearch #MentalHealthAwareness #HealthcareInnovation

Understanding ADHD & Addiction: Bridging Psychiatry and Addiction Medicine

🎙 Presenter: Dr. Hamid-Reza Rahmanian
🏥 South West London & St. George’s Mental Health NHS Trust, United Kingdom
🎓 Honorary Senior Lecturer, St George’s, University of London
📌 Presentation Type: Oral Presentation
🧠 Title: The Relationship Between ADHD and Addictive Behaviours: A Review

---

🔬 Presentation Highlights

∙ Adult ADHD Reality: ADHD frequently persists into adulthood and is often underdiagnosed.
∙ High-Risk Comorbidity: ADHD significantly increases the risk of substance use disorders, behavioural addictions, mood disorders, and personality disorders.
∙ Bidirectional Link: ADHD symptoms such as impulsivity can drive addiction, while chronic substance use may worsen ADHD symptoms.
∙ Behavioural Addictions: Strong associations with internet, shopping, and other non-substance addictions.
∙ Clinical Complexity: Treating ADHD alongside substance use disorders remains challenging, especially with stimulant medications.
∙ Treatment Insights: Emphasizes careful differentiation between ADHD patients with and without stimulant/cocaine addiction.
∙ Screening Matters: Recommends routine cross-screening for ADHD and SUD in both mental health and addiction services.
∙ Integrated Care: Highlights the importance of combining pharmacological treatment with psychosocial interventions for better outcomes.

---

👨‍⚕️ About the Speaker

Dr. Hamid-Reza Rahmanian is a Consultant Psychiatrist and Associate Clinical Director for Sutton Community Mental Health Services at South West London & St George’s NHS Trust. He is a Fellow of the Royal College of Psychiatrists (FRCPsych) with subspecialty experience in perinatal psychiatry.
∙ Over 25 years of clinical and academic experience
∙ Expertise in mood disorders, psychosis, ADHD, eating and personality disorders
∙ Strong advocate of transcultural psychiatry; fluent in Farsi
∙ Leader in community psychiatry transformation, service redesign, and quality improvement
∙ Dedicated educator and mentor in undergraduate and postgraduate medical training
∙ Practices a holistic, biopsychosocial, NICE-aligned approach to mental healthcare

---

🔗 Join the Conference
🧠 Event: International Conference onAddiction Medicine, Mental Health and Psychiatry
📅 Dates: March 23–25, 2026
📍 Venue: Singapore & Online
🌐 Website: https://addiction.miconferences.com/

---

#ADHD #AddictionMedicine #MentalHealthConference #Psychiatry #SubstanceUseDisorder #BehavioralAddictions #NeurodevelopmentalDisorders #AdultADHD #MentalHealthResearch #TransculturalPsychiatry #CommunityPsychiatry #AddictionResearch #PsychiatryConference #MentalHealth2026 #SingaporeConference #MIconferences

Smartphone Addiction, Mental Health, and the Screen Trap of the Digital Age

Presenter: Dr. Anita Handore Salunke 
Founder & Director, PhytoElixir Pvt. Ltd., India
Presentation Type: Oral Presentation (In-Person & Online)
Title: Smartphone addiction, mental health, and screen trap ofdigital age

---

🔬 Presentation Highlights
∙ Focus: Smartphone addiction as an emerging behavioral disorder within mental health and psychiatry.
∙ Core Insight: Excessive smartphone use mirrors substance addiction through cravings, withdrawal-like symptoms, and impaired control.
∙ Neurobiological Basis: Dopamine-driven reward pathways reinforced by notifications, gaming, and online validation.
∙ Psychological Drivers: Stress relief, loneliness, low self-esteem, gratification, and social comparison.
∙ High-Risk Groups: Adolescents and young adults due to identity formation, reduced self-regulation, and high digital exposure.
∙ Health Impact: Anxiety, depression, sleep disturbances, attention deficits, social isolation, and reduced productivity.
∙ Physical Effects: Vision strain, musculoskeletal issues, sedentary lifestyle disorders, fatigue, and obesity.
∙ Interventions: Cognitive Behavioral Therapy (CBT), mindfulness-based therapies, digital detox programs, and screen-time regulation tools.
∙ Future Direction: Integrating clinical care, education, community engagement, and policy to promote healthy digital habits.

---

👩‍🔬 About the Speaker
Dr. Anita V. Handore Salunke is a distinguished bioscientist, entrepreneur, and innovator with over two decades of expertise in Microbiology, Phyto-Biotechnology, and Phyto-Nutraceuticals.
∙ Founder & Director of PhytoElixir Pvt. Ltd., an innovation-driven phyto-biotech startup in India.
∙ Holds PhD in Microbiology and M.Phil. in Environmental Science.
∙ Granted two process patents, with additional patents filed in Agriculture Biotechnology, Food Technology, and Healthcare.
∙ Authored 102+ research publications, book chapters, and books with leading global publishers.
∙ Editorial board member, research guide for MSc & PhD scholars, and Program Advisory Committee member.
∙ Recipient of 21+ State, National, and International awards for scientific excellence and social impact.

---

🔗 Join the Conference
Event: International Conference on Addiction Medicine, Mental Health andPsychiatry
📅 March 23–25, 2026
📍 Singapore & Online
📝 Register: https://addiction.miconferences.com/register

---

#AddictionMedicine #MentalHealthConference #PsychiatryConference #SmartphoneAddiction #DigitalWellbeing #BehavioralAddiction #MentalHealthAwareness #CBT #DigitalDetox #Neuroscience #PublicHealth
#SingaporeConference #HybridConference #AddictionResearch
#MentalHealth2026 #MathewsConferences

🧠 Advancing Addiction & Mental Health Care Through Brain Stimulation Research

Presenter: Bess Yin Hung Lam
Affiliation: Hong Kong Shue Yan University, Hong Kong
Presentation Type: Oral Presentation
Title: The effect of high-definition transcranial direct currentstimulation (HD-tDCS) on psychological functions in drug addicts: a pilot study

🔬 Presentation Highlights
• Focus: Exploring the role of HD-tDCS in improving psychological functions and reducing antisocial behavior among drug addicts.
• Study Aim: To evaluate whether targeted brain stimulation can positively impact drug craving and antisocial tendencies.
• Methodology:
– Randomized assignment to active HD-tDCS or sham stimulation groups.
– 13-minute stimulation sessions, twice daily, over 5 days within 2 weeks.
– Targeted stimulation of the right orbitofrontal cortex (OFC) using Soterix HD-tDCS (1.5 mA).
• Assessment: Psychological functions, mood, adverse effects, drug cravings, and antisocial behavior measured pre- and post-stimulation.
• Key Findings: Notable improvements in several psychological functions following HD-tDCS.
• Impact: Offers valuable clinical and theoretical insights for rehabilitation professionals, correctional services, and policymakers working in addiction and antisocial behavior prevention.

👩‍🔬 About the Speaker
Bess Yin Hung Lam is an interdisciplinary researcher specializing in the neural and psychosocial mechanisms of social cognition, antisocial behavior, and schizophrenia-spectrum disorders.
• Research spans autism, special education needs, drug addiction, and the gut–brain axis.
• Actively involved in international collaborations across Hong Kong, Mainland China, Canada, Australia, and the United States.

🔗 Join the Conference
Event: International Conference on Addiction Medicine, Mental Health andPsychiatry
📅 Dates: March 23–25, 2026
📍 Venue: Singapore & Online
🌐 Website: https://addiction.miconferences.com/

#AddictionMedicine #MentalHealthConference #PsychiatryResearch #BrainStimulation #HDTDCS #Neuroscience #AddictionRecovery #MentalHealthInnovation #PsychologyResearch #RehabilitationScience #SingaporeConference #HybridConference #MathewsConferences